Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Newsflash Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 569

Lixisenatide Success

Lixisenatide Success

Next possible GLP-1 diabetes drug from Sanofi-Aventis (lixisenatide) has success in a late stage trial, reducing A1c and body weight without increasing risk of hypoglycemi

BYDUREON™ recommended for approval in Europe.

BYDUREON would be first once-weekly treatment for adults with Type 2 diabetes.

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 14 April, 2011 and appeared in  Issue 569

Past five issues: Issue 770 | Diabetes Clinical Mastery Series Issue 229 | Issue 769 | Diabetes Clinical Mastery Series Issue 228 | Issue 768 |

2015 Most Popular Articles:

What Is the Best Time to Exercise with Diabetes?
Posted February 05, 2015
Change Language to Combat Feelings of Failure
Posted February 08, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
A Probiotic That Helps Control Diabetes
Posted February 06, 2015
Eye Scan Predicts Peripheral Neuropathy in Type 1 Diabetes
Posted January 30, 2015
Type 2 Diabetes Remission Very Rare in Non-Bariatric Surgery Patients
Posted January 30, 2015
Human-Insulin Producing Stem Cells
Posted February 13, 2015
Bariatric Surgery for Diabetics May Not Be Worth The Risk
Posted February 13, 2015
Are DPP-4 Inhibitors Really a Risk Factor for Pneumonia?
Posted January 30, 2015
Higher BMI Leads to More Diabetes Complications Diagnosed among Older Adults
Posted January 30, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients are at goal for A1c, BP and cholesterol?
CME/CE of the Week
Category: Nursing
CE Credits: 1.0



Search Articles On Diabetes In Control